sur Nanohale AG (ETR:FYB)
Formycon AG Hosts Conference Call and Attends Investor Conferences
Formycon AG, a Germany-based biosimilar developer, is set to reveal its 2026 nine-month financial results on November 12. The company's management will discuss financial highlights and future plans during a live conference call. Interested parties are invited to register online to participate. The call is scheduled for 3:00 PM CET and will be conducted in English.
Additionally, Formycon will engage with investors at several international conferences. Key events include the Jefferies London Healthcare Conference and the Deutsche Börse Equity Forum in November. Further engagements are planned for early 2027, including participation in conferences in San Francisco and Hamburg.
These initiatives reflect Formycon’s commitment to transparency and its active role in fostering discussions with global investors. More details are available on the company’s website.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Nanohale AG